NorthWest Biotherapeutics Inc (NWBO)

[pqr]

Ike/Doc Logic: Statistics apparently are accepted as evidence in securities fraud litigation. My cursory reading of the article from which I provide the below quote ties disclosure to share price. I would think that disclosure of demonstrably false information (if that could be shown) could be used in conjunction with share price decline.

I have a question whether statistical evidence would be sufficient to overcome a Summary Judgment motion or would be admissible only as to other issues (damages, specifically). From the reference to “fraud” claims in the excerpt it seems perhaps both applications.

“The event study—a statistical tool borrowed from financial economics—has become a critical tool in securities fraud litigation. In litigation, event studies are used to measure the extent to which market prices react to the release of new information. Their results are introduced as evidence on the efficiency the market in which the securities trade, the impact of the fraudulent disclosures on market prices, the causal relationship between the fraud and plaintiff’s economic harm, and the appropriate calculation of damages. Courts vary both in the extent to which they require the use of an event study and the degree to which they accept other evidence with respect to these issues, but a properly-conducted event study is often a key factor.



Here’s the blurb: